1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: NCI-86-C-183E, NCI-T86-0225N, T86-0225
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: AECM-9102059, NCI-T91-0050D, T91-0050
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: PCI-9038, NCI-T91-0133O, T91-0133
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9219
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: ECOG-E5Y92, E5Y92
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SPRI-C94-049, SCH-C94-049-01, NCI-V95-0654
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: SPRI-C94-048, SCH-C94-048-01, NCI-V95-0655
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 16 Sponsor: NCI Protocol IDs: SWOG-9711, S9711
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: RPCI-DS-95-10, NCI-V97-1360
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: LAC-USC-10M991, NCI-G00-1837, NCI-T99-0102, NCT00006113, T99-0102
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CCF-RPC-3209, NCI-T89-0218O, T89-0218
|
|
12.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-89-C-166, NCI-T89-0119N, T89-0119
|
|
13.
|
Phase: Phase II Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: IDB-IL4/MELANOMA, AECM-9003063, CHNMC-COH-9002390031, LUMC-2347, NEMCH-CSU-1919, UCSF-H6042-05366-01, UTHSC-8905011208, NCI-T90-0030O, T90-0030
|
|
14.
|
Phase: Phase II Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: IDB-IL4/RENAL, AECM-9003064, CHNMC-COH-9002290041, LUMC-2348, NEMCH-CSU-1918, UTHSC-8905011209, NCI-T90-0032O, T90-0032
|
|
15.
|
Phase: Phase II Type: Treatment Status: Completed Age: over 1 to under 21 Sponsor: NCI Protocol IDs: NCI-90-C-210B, NCI-T90-0110N, T90-0110
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CCF-RPC-3209R, NCI-T92-0172O, T92-0172
|
|
17.
|
Phase: Phase II Type: Treatment Status: Closed Age: 15 to 70 Sponsor: NCI Protocol IDs: UARK-91005, NCI-T91-0115O, T91-0115
|
|
18.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: WSU-C-1041-92, NCI-T92-0167D, T92-0167
|
|
19.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CWRCC-ICC-1A92, NCI-T92-0161D, T92-0161
|
|
20.
|
Phase: Phase II Type: Treatment Status: Completed Age: adult Sponsor: NCI Protocol IDs: SWOG-9230
|
|
21.
|
Phase: Phase II Type: Treatment Status: Completed Age: adult Sponsor: NCI Protocol IDs: SWOG-9228
|
|
22.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-917851, NCCTG-91-78-51
|
|
23.
|
Phase: Phase I Type: Treatment Status: Completed Age: under 21 Sponsor: NCI Protocol IDs: SJCRH-IL4, NCI-T94-0101D, T94-0101
|
|
24.
|
Phase: Phase I Type: Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9574
|
|
25.
|
Phase: Phase I Type: Treatment Status: Completed Age: 15 to 65 Sponsor: NCI Protocol IDs: NCI-88-C-141B, NCI-T88-0161N, T88-0161
|